| Protocol No. | PI | Title |
|---|
| OSU-0107 | Doreen Agnese | Prospective Cohort Study of BRCA1 & BRCA2 Carriers |
| OSU-10129 | Dawn Allain | The Value of Genetic Counselors in Genetic Testing for Hereditary Breast-Ovarian Cancer |
| OSU-9942 | Barbara Andersen | Stress Immunity & Breast Cancer Recurrence |
| CALGB-60202 | Clara Bloomfield | Embedded companion to CALGB 40101: Drug Metabolism and Transport PG in Breast CA patients on CALGB 40101 |
| OSU-09142 | William Carson | Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients |
| OSU-06010 | Kevin Evans | Lymph Node Evaluation in the Axilla of Symptomatic Older Women During Breast Sonography. |
| NSABP-B-43 | William Farrar | A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy. |
| NSABP-B-47 | William Farrar | Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer |
| OSU-12033 | Gayle Gordillo | MASTECTOMY RECONSTRUCTION OUTCOMES CONSORTIUM (MROC) STUDY |
| OSU-07123 | Stacey Hindy | Epidemiology of Breast Implant Infections in Post-Mastectomy Breast Cancer Patients Undergoing Breast Reconstruction
|
| OSU-06007 | Kimberly Kelly | Perceived Recurrence Risk of Breast Cancer. |
| OSU-09005 | Kimberly Kelly | Breast Cancer Patients Perceptions of Recurrence Risk and Treatment Expectations |
| OSU-06137 | Janice Kiecolt-Glaser | Breast Cancer Survivors: Physical Activity, Inflammation, Fatigue, and Distress |
| CALGB-150714 | Rachel Layman | Embedded Companion Study to CALGB-40502 |
| CALGB-60704 | Rachel Layman | Embedded Companion Study to CALGB-40502 |
| OSU-0252 | Joanne Lester | Evaluation and Treatment of Urogenital Atrophy in High Risk Breast Patients and Breast Cancer Survivors |
| OSU-11092 | Joanne Lester | Effect of Survivorship Care Planning on Distress: A Randomized Control Trial with Leukemia and Breast Cancer Survivors.
|
| SWOG-S1007 | Maryam Lustberg | A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or Less |
| OSU-12127 | Maryam Lustberg | A randomized, double-blind, placebo controlled, phase II study of BKM120 plus paclitaxel in patients with HER2 negative inoperable locally advanced or metastatic breast cancer, with or without PI3K pathway activation |
| OSU-11022 | Maryam Lustberg | Prevention of Aromatase Inhibitor-Induced Joint Symptoms with Omega 3 Fatty Acid Supplementation: a randomized placebo controlled pilot study |
| OSU-08140 | Maryam Lustberg | Isolation and Characterization of Circulating Tumor Cells in Localized and Metastatic Breast Cancer Patients by Immunocytochemical and PCR Detection after Immunomagnetic Cell Enrichment |
| CALGB-60701 | Ewa Mrozek | Embedded Companion to CALGB-40601
|
| CALGB-150702 | Ewa Mrozek | Embedded Companion to CALGB-40601 |
| OSU-12061 | Erin Olson | A two-cohort, open-label, multicenter Phase II trial assessing the efficacy and safety of pertuzumab given in combination with trastuzumab and vinorelbine in first line patients with HER2-positive advanced (metastatic or locally advanced) breast cancer |
| OSU-12109 | Erin Olson | YOUNG AND STRONG: An Education and Supportive Care Intervention Study for Young Women with Breast Cancer |
| OSU-12156 | Douglas Post | Increasing Adherence to Adjuvant Hormonal Therapy among Breast Cancer Patients:
Phase I - Intervention Development
|
| OSU-09012 | Douglas Post | Developing a communication Tool for Appalachian Breast Cancer Survivors |
| OSU-07015 | Stephen Povoski | 8 Gauge Mammotome Vacuum-Assisted Biopsy Technique: Retrospective Chart Review |
| OSU-07016 | Stephen Povoski | Assessment of Nine Standardized Quadrantectomy Resection Margins During Breast Conservation Surgery for Breast Cancer: Retrospective Chart Review |
| ECOG-E2108 | Stephen Povoski | A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
|
| RTOG-1119 | Allison Quick | PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY IN COMBINATION WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASIS FROM HER2-POSITIVE BREAST CANCER A COLLABORATIVE STUDY OF RTOG AND KROG |
| OSU-10097 | Bhuvaneswari Ramaswamy | A Randomized Phase II Study of Fulvestrant vs. Fulvestrant in Combination with Bortezomib in Women with ER Positive Metastic Breast Cancer |
| OSU-08153 | Bhuvaneswari Ramaswamy | A Phase II Open-label Study of Subcutaneous CPG ODN (PF03512676) in Combination with Trastuzumab in Patients with Metastatic Breast Cancer |
| CALGB-150605 | Bhuvaneswari Ramaswamy | Embedded Companion Study to CALGB-40503 |
| CALGB-60605 | Bhuvaneswari Ramaswamy | Embedded Companion Study to CALGB-40503 |
| CALGB-150804 | Bhuvaneswari Ramaswamy | Embedded companion study to CALGB 70604 |
| CALGB-60803 | Bhuvaneswari Ramaswamy | Embedded companion study to CALGB 70604 |
| OSU-11127 | Leigha Senter-Jamieson | The impact of pregnancy during and after breast cancer on survival in carriers of BRCA1 and BRCA2 mutations |
| OSU-12112 | Charles Shapiro | A Randomised, Double-blind, Parallel-group, Multicentre, Phase III Study to Compare the Efficacy and Tolerability of Fulvestrant (FASLODEXTM) 500 mg with Anastrozole (ARIMIDEXTM) 1 mg as Hormonal Treatment for Postmenopausal Women with Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer Who Have Not Previously Been Treated With Any Hormonal Therapy (FALCON) |
| OSU-07088 | Charles Shapiro | The Columbus Breast Cancer Tissue Bank |
| OSU-0109 | Charles Shapiro | Human Breast Cancer and National Breast Tissue Bank |
| OSU-05082 | Amanda Toland | Variants in High Risk Breast Cancer Genes and Contribution to Cancer Risk. |
| OSU-05102 | Amanda Toland | Identification of Human Cancer Susceptibility & Resistance Genes. |
| OSU-10152 | Miguel Villalona | Phase 1 Study of IMC-CS4, a Monoclonal Antibody Targeted to the CSF-1 Receptor (CSF-1R), in Subjects With Advanced Solid Tumors Refractory to Standard Therapy or for Which No Standard Therapy is Available |
| CALGB-150709 | Robert Wesolowski | Embedded Companion to CALGB-40603 |
| CALGB-60703 | Robert Wesolowski | Embedded Companion to CALGB-40603 |
| OSU-12187 | Robert Wesolowski | Single-Patient Compassionate Use Treatment using Trastuzumab Emtansine (T-DM1) For Her2-Positive Metastatic Breast Cancer |
| OSU-12018 | Robert Wesolowski | A Phase 1b Study to Assess the Safety of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors |
| OSU-12020 | Robert Wesolowski | MINT I Multi-Institutional Neo-adjuvant Therapy MammaPrint project I |
| OSU-12078 | Robert Wesolowski | THE BEACON STUDY (BREAST CANCER OUTCOMES WITH NKTR-102):A PHASE 3 OPEN-LABEL, RANDOMIZED, MULTICENTER STUDY OF NKTR-102 VERSUS TREATMENT OF PHYSICIAN¿S CHOICE (TPC) IN PATIENTS WITH LOCALLY RECURRENT OR METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH AN ANTHRACYCLINE, A AXANE, AND CAPECITABINE |
| RTOG-1005 | Julia White | A PHASE III TRIAL OF ACCELERATED WHOLE BREAST IRRADIATION WITH HYPOFRACTIONATION PLUS CONCURRENT BOOST VERSUS STANDARD WHOLE BREAST IRRADIATION PLUS SEQUENTIAL BOOST FOR EARLY-STAGE BREAST CANCER |
| CALGB-40903 | Lisa Yee | PHASE II STUDY OF NEOADJUVANT LETROZOLE FOR POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR POSITIVE DUCTAL CARCINOMA IN SITU [DCIS) |
| CALGB-70806 | Lisa Yee | Vitamin D and Breast Cancer Biomarkers |
| OSU-10024 | Lisa Yee | Omega 3 Fatty Acids and Breast Cancer Prevention: Protective Benefits of Increased Fish Consumption |
| OSU-08189 | Lisa Yee | Breast Cancer Prevention by Letrozole in High Risk Women |
| OSU-0253 | Lisa Yee | Breast Fine Needle Aspiration and Breast Duct Fluid Collection in High Risk Breast Patients. |
| OSU-9990 | Lisa Yee | Fatty Acids & Peroxisome Proliferator-Activated Receptors in Breast Cancer Prevention |